Ex Parte Conway et alDownload PDFPatent Trial and Appeal BoardJan 25, 201813682406 (P.T.A.B. Jan. 25, 2018) Copy Citation United States Patent and Trademark Office UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O.Box 1450 Alexandria, Virginia 22313-1450 www.uspto.gov APPLICATION NO. FILING DATE FIRST NAMED INVENTOR ATTORNEY DOCKET NO. CONFIRMATION NO. 13/682,406 11/20/2012 Anthony J. Conway 101674.0068P 1025 7590 RUT AN & TUCKER, LLP 611 ANTON BLVD SUITE 1400 COSTA MESA, CA 92626 01/29/2018 EXAMINER WENG, KAI H ART UNIT PAPER NUMBER 3761 NOTIFICATION DATE DELIVERY MODE 01/29/2018 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address(es): patents @ rutan. com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte ANTHONY J. CONWAY and SARAH L. GRINDE Appeal 2017-000639 Application 13/682,406 Technology Center 3700 Before BRETT C. MARTIN, THOMAS F. SMEGAL, and LISA M. GUIJT, Administrative Patent Judges. GUIJT, Administrative Patent Judge. DECISION ON APPEAL STATEMENT OF THE CASE Appellants1 seek our review under 35 U.S.C. § 134 of the Examiner’s decision2 rejecting claims 1—10, 12—20, 23, and 24. We have jurisdiction under 35 U.S.C. § 6(b). We AFFIRM—IN—PART. CLAIMED SUBJECT MATTER Claims 1 and 20 are the independent claims on appeal. Claim 1, reproduced below, is illustrative of the subject matter on appeal. 1 Appellants identify Rochester Medical Corporation as the real party in interest. Appeal Br. 4. 2 Appeal is taken from the Final Office Action dated June 5, 2015. Appeal 2017-000639 Application 13/682,406 1. A catheter retention sheath, comprising: a sheath configured to fit over a penis; the sheath comprising a catheter retainer, the catheter retainer configured to couple to a shaft of a urinary catheter; the catheter retainer defining an aperture, a first portion of the aperture being configured to allow axial movement of the shaft of the urinary catheter through the aperture, a second portion of the aperture being configured to retain the shaft of the urinary catheter. REJECTIONS I. Claims 1—7, 10, 12, and 20 stand rejected under 35 U.S.C. § 102(b) as anticipated by Rowland (US 4,419,097; issued Dec. 6, 1983).3 II. Claim 8 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Rowland and Viswanathan (US 2007/0149946 Al; published June 28, 2007). III. Claim 9 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Rowland and Nielsen (US 1,661,494; issued Mar. 6, 1928). IV. Claims 13—17 and 19 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Rowland and Cisko (US 2008/0215021 Al; issued Sept. 4, 2008). V. Claim 18 stands rejected under 35 U.S.C. § 103(a) as unpatentable over Rowland, Cisko, and Highgate (US 4,768,503; issued 3 The Examiner’s inclusion of claim 11 in the Final Action is a typographical error; claim 11 is cancelled. Final Act. 2; Appeal Br. 4. 2 Appeal 2017-000639 Application 13/682,406 Sept. 6, 1988). VI. Claims 23 and 24 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Rowland. ANALYSIS Rejection I Independent claims 1 and 20, and dependent claims 2, 3, and 12 Regarding independent claim 1, the Examiner finds, inter alia, that Rowland discloses a catheter retainer (i.e., housing 14, which comprises attachment 10 for use in combination with a catheter tube 12) having an aperture (i.e., aperture 20 and slit 24) with a first portion (i.e., aperture 20) configured to allow axial movement a shaft of a catheter through the aperture, and a second portion (i.e., slit 24) configured to retain the catheter shaft. Final Act. 2 (citing Rowland 2:47—50, 58—60); see also Rowland 2:27-29, 36-38. Appellants argue that Rowland’s slit 24 cannot disclose a second portion of the aperture, as claimed, because “[a]s used in the specification and claims, a slit is not an aperture.” Appeal Br. 8. In support, Appellants maintain that Figure 3 of Appellants’ Specification ‘“schematically illustrates tube 5 showing lumen 17 and slit 13, which form catheter retention opening 15,’” whereby the Specification “differentiates between a slit and an opening or aperture.” Id. (quoting Spec. 1264 (16:12—13), Fig. 4 Appellants cite to both the US publication of Application No. 13/682,406 (i.e., US 2014/0142554 Al; published May 22, 2014), for example, by paragraph number, and also to the Specification as originally filed, for 3 Appeal 2017-000639 Application 13/682,406 3). Appellants further maintain that “a slit is never used as one of the portions of the aperture” in the Specification. Reply Br. 4. We understand Appellants’ argument to be that because Appellants’ Specification identifies catheter retention opening 15 as a second portion of an aperture (which retains the catheter shaft because the catheter shaft is urged into lumen 17 (see, e.g., Spec. 16:12—13)), and also because slit 13, as described in Appellants’ Specification, is not what is intended to be the claimed second portion, Rowland’s slit 24 cannot disclose a second portion of the aperture, as claimed, or put another way, the claimed second portion cannot read on Rowland’s slit. As set forth supra, claim 1 merely requires an aperture* * * 5 (or opening) to have first and second portions (each configured to perform certain functions), and thus, neither requires the claimed second portion to be a lumen nor excludes the claimed second portion from being a slit. An ordinary meaning of the term “slit,” consistent with the Specification, is “a long narrow cut or opening” (Webster’s Third New Int’l Dictionary 2144 (1993)), and therefore, a slit may be a specific type of aperture (or opening), for example, a long, narrow one. See also Ans. 5 (“[a] slit is a form of an aperture.”). Here, Rowland discloses that slit 24 is not only a cut example, by page and line number. See Appeal Br. 8 (citing 126); id. at 9 (citing “p. 1, lines 11—13, 19-21; p. 5, lines 4—6.”). We cite to the original Specification as filed. 5 An ordinary meaning of the claim term aperture, consistent with the Specification is “an opening or an open space” (Webster’s Third New Int’l Dictionary 99 (1993)). 4 Appeal 2017-000639 Application 13/682,406 in housing 14, but also an opening through which the catheter (tube 12) may be forced. See Rowland 2:58—61 (“it may be desirable to place the housing 14 over the tube 12 in a transverse direction by forcing the tube 12 through the slit 24 until the tube 12 reaches the aperture 20.”). Thus, in view of the language of claim 1, Appellants’ argument does not apprise us of error in the Examiner’s finding that Rowland’s slit 24 is a second portion of an aperture. Appellants also argue that the principle of claim differentiation precludes Rowland’s slit 24 from being interpreted as an aperture, because claim 10 recites “a slit as being something different and distinct from the aperture portions.” Appeal Br. 9. Indeed, claim 10 depends from claim 1 and further recites “wherein the catheter retainer further defines a slit that couples the first portion of the aperture to the second portion of the aperture.” Appeal Br. 21 (Claims App’x). However, claim 10 requires a slit in addition to the claimed second portion of the aperture, and thus, we are not apprised of error in the Examiner’s findings that Rowland’s slit 24 discloses the second portion of the aperture, as recited in claim 1. Appellants further argue that “the catheter in Rowland is not ‘retained’ in the slit 24 and never would be.” Appeal Br. 9. In support, Appellants submit that the claim term “retain” is used in the Specification “to indicate that movement is inhibited,” and that “a portion of the Rowland device through which the catheter only moves on its way to the central opening cannot be said to ‘retain’ the catheter.” Id. (citing Spec. 1:11—13, 19-21, 5:4—6). Appellants argue that “[wjhile retention can include reduced movement, it does not logically follow that any reduced movement is 5 Appeal 2017-000639 Application 13/682,406 therefore retention” (Reply Br. 4), concluding that Rowland’s slit 24 “is not designed to hold the catheter for any length of time; rather, the slit is merely a way for the catheter to move from outside the device to the central opening prior to catheterization.” Id. at 5. An ordinary meaning of the claim term “retain,” consistent with the Specification, is “to hold secure or intact (as in a fixed place or condition).” Webster’s Third New Int’l Dictionary 1938 (1993). As set forth supra, claim 1 requires the second portion of the aperture to be “configured to retain the shaft of the urinary catheter,” however, claim 1 does not require the shaft to be retained in the second portion of the aperture, as argued by Appellants. Rowland discloses that “it may be desirable to place the housing 14 over the tube 12 in a transverse direction by forcing the tube 12 through the slit 24 until the tube 12 reaches the aperture 20” (Rowland 2:58—61), and that after the tube 12 reaches aperture 20 and the slit is no longer being forced open, “aperture 20 is in a snug engagement with the outer periphery of the tube 12” {id. at 3:2 4). Rowland also teaches that housing 14 “is relatively rigid, but sufficiently yieldable for facilitating [this] use.” Id. at 2:28—33. Thus, we determine that a preponderance of evidence supports the Examiner’s finding that Rowland explicitly teaches that when tube 12 is not being forced through slit 24, slit 24 is configured to return to a position that, in turn, maintains aperture 20 in a position of snug engagement with the shaft of the catheter, and therefore, Rowland’s slit 24 is “configured to retain the shaft of the urinary catheter,” as claimed. 6 Appeal 2017-000639 Application 13/682,406 Finally, Appellants argue that Rowland requires “the catheter [to] be coupled with the housing prior to the catheter being inserted into the patient” and “teaches moving the catheter through the slit prior to insertion into the patient.” Appeal Br. 10. However, as correctly determined by the Examiner, “the claims do not recite any order.” Ans. 7. Thus, Appellants’ argument does not apprise us of error in the Examiner’s findings. Accordingly, we sustain the Examiner’s rejection of independent claim 1 under 35 U.S.C. § 102(b) as anticipated by Rowland. Appellants present the same arguments for the patentability of independent claim 20 as presented for the patentability of claim 1, and therefore, for the same reasons as set forth supra, we sustain the Examiner’s rejection of claim 20. See Appeal Br. 8—10; Reply Br. 4—6. Appellants chose not to present separate arguments for the patentability of claims 2, 3, and 12, and therefore, we also sustain the Examiner’s rejection of claims 2, 3, and 12 under 35 U.S.C. § 102(b) as anticipated by Rowland. See Appeal Br. 14; Reply Br. 9. Dependent claim 4 The Examiner relies on Rowland for disclosing the limitation of claim 4, which depends from claim 1: “wherein the second portion of the aperture is configured to immobilize the urinary catheter in the sheath.” Final Act. 3 (citing Rowland 2:58—60); Appeal Br. 20 (Claims App’x). Appellants argue that “a catheter is not held in the Ro[w]land slit 24, let alone immobilized in the slit 24, and the catheter is only in the slit 24 as it moves on its way to the first portion aperture.” Appeal Br. 11. 7 Appeal 2017-000639 Application 13/682,406 Notably, claim 4 does not require the second portion to be configured to immobilize the catheter in the second portion (i.e., Rowland’s slit 24), as argued by Appellants; rather, claim 4 requires the second portion to be configured to immobilize the catheter in the sheath. Notwithstanding, a preponderance of evidence fails to support the Examiner’s finding that Rowland’s slit 24 is configured to immobilize6 the catheter in the sheath, because Rowland’s disclosure of a “snug engagement” between aperture 20 and the periphery of catheter tube 12 stops short of disclosing immobilization. See Rowland 2:54—56 (disclosing “manually sliding the housing 14 along the tube”). Accordingly, we do not sustain the Examiner’s rejection of claim 4 under 35 U.S.C. § 102(b) as anticipated by Rowland. Dependent claim 5 The Examiner relies on Rowland for disclosing the limitation of claim 5, which depends from claim 1: “wherein, after the urinary catheter is inserted in the subject, the second portion of the aperture is configured to restrict motion of the urinary catheter with respect to the subject’s penis and bladder.” Final Act. 3; Appeal Br. 20 (Claims App’x). Appellants argue that “the Rowland slit 24 is not used to restrict the motion of a catheter, and the catheter is only in the slit 24 as it moves on its 6 An ordinary meaning of the claim term “immobilize,” consistent with the Specification, is “to make immobile : fix in place or position : render incapable of movement.” Webster’s Third New Int’l Dictionary 1130 (1993). 8 Appeal 2017-000639 Application 13/682,406 way to the alleged first portion aperture.” Appeal Br. 11; see also Reply Br. 8. As discussed supra, a preponderance of the evidence supports the Examiner’s finding that Rowland’s slit 24 is configured to retain the shaft of the catheter, as set forth in claim 1. Rowland also discloses that “aperture 20 is in a snug engagement with the outer periphery of the tube 12 and thus substantially precludes relative movement between the tube and the flesh of the male member.” Rowland 3:2—6. Thus, a preponderance of the evidence supports the Examiner’s finding that when tube 12 is not being forced through slit 24, slit 24 is configured to return to a position that maintains aperture 20 in a position of snug engagement with the shaft of the catheter, such that after tube 12 is inserted into the subject, motion is restricted between the catheter (i.e., tube 12) and the subject, as required by claim 5. Accordingly, we sustain the Examiner’s rejection of claim 5 under 35 U.S.C. § 102(b) as anticipated by Rowland. Dependent claim 6 The Examiner relies on Rowland for disclosing the limitation of claim 6, which depends from claim 1: “wherein the second portion of the aperture is, in a relaxed state, approximately the same size as or smaller than the outside diameter of the shaft of the urinary catheter.” Final Act. 3 (citing Rowland, Fig. 1); Appeal Br. 20 (Claims App’x). Appellants argue that Figures 1 and 3 of Rowland “show that slit 24 is much longer than the diameter of the opening 20 and a catheter 36 inserted through the opening 20.” Appeal Br. 13. The Examiner responds that “the 9 Appeal 2017-000639 Application 13/682,406 diameter of the slit from side to side (width) is smaller than the outside diameter of the shaft of the urinary catheter.” Ans. 9. Appellants reply that “it is axiomatic that a slit width cannot properly be considered a diameter at least because a slit does not have a circular cross-section.” Reply B. 8. Neither claim 6 nor claim 1 from which claim 6 depends requires the second portion of the aperture to have a circular shape. Thus, we are not persuaded by Appellants’ argument. Moreover, in a relaxed state, Rowland’s slit 24 appears closed, as depicted in Figure 1 of Rowland, and therefore, a preponderance of the evidence supports the Examiner’s finding that Rowland’s slit 24 has a smaller size than the outside diameter of the shaft of the urinary catheter. As discussed supra, slit 24 must be forced open to allow a catheter to pass there through. Accordingly, we sustain the Examiner’s rejection of claim 6 under 35 U.S.C. § 102(b) as anticipated by Rowland. Dependent claim 7 The Examiner relies on Rowland’s housing 187 for disclosing the limitation of claim 7, which depends from claim 1: “a neck portion that defines part or all of the second portion of the aperture.” Final Act. 3 (citing Rowland, Fig. 1); see also Rowland 3:10; Appeal Br. 20 (Claims App’x). The Examiner determines that “[t]he narrowing section” of housing 18 “is interpreted as constituting a neck portion.” Ans. 9. 7 Rowland also refers to reference numeral 18 as “arcuate or substantially spherical wall 18” (Rowland 2:35—36) and as “closed end 18” (id. at 2:48). 10 Appeal 2017-000639 Application 13/682,406 Appellants submit that “slit 24 slopes down the side of a semispherical portion of the housing 18, with no portion of the slit 24 being associated with anything that might be considered a neck to one of ordinary skill in the art.” Appeal Br. 13; see also Reply Br. 9 (arguing that the Examiner’s finding “does not match any reasonable definition of neck and has no basis in the specification”). An ordinary meaning of the claim term “neck,” consistent with the Specification, is “a part reduced in circumference.” Webster’s Third New Int’l Dictionary at 1511. Rowland discloses that housing 14 “is closed by an arcuate or substantially spherical wall 18,” such that the circumference of housing 14 is reduced toward its closed end-wall, and depicts slit 24 on the arcuate portion of wall 18. Rowland 2:33—36; Fig. 1. Thus, a preponderance of evidence supports the Examiner’s finding that Rowland’s housing 14 comprises a neck portion (spherical wall 18) that defines part or all of the second portion (i.e., slit 24), as claimed. Accordingly, we sustain the Examiner’s rejection of claim 7 under 35 U.S.C. § 102(b) as anticipated by Rowland. Dependent claim 10 The Examiner relies on Rowland for disclosing the limitation of claim 10, which depends from claim 1: “wherein the catheter retainer further defines a slit that couples the first portion of the aperture to the second portion of the aperture.” Final Act. 3 (citing Rowland, Fig. 1); Appeal Br. 20 (Claims App’x). 11 Appeal 2017-000639 Application 13/682,406 Appellants argue that “[tjhere is no separate slit that connects slit 24 to the alleged first portion.” Appeal Br. 14. The Examiner responds by presenting an annotated Figure 1 of Rowland, reproduced below. Ans. 6. The Examiner’s annotated Figure 1 of Rowland is a perspective view of a catheter tube attachment, wherein the Examiner identifies structures corresponding to the claimed first and second portions of an aperture, and also a slit, as recited in claim 10, which depends from claim 1. See Ans. 6; Rowland 2:3—4. Appellants reply that “[t]he Examiner has not identified a component that satisfies the second portion and a separate component that satisfies the slit requirement or explained how they are coupled by a slit.” Reply Br. 9. However, Appellants’ argument does not address the Examiner’s findings as clarified in the Examiner’s annotated Figure 1 of Rowland set forth supra. Moreover, the claim term “portion” means “a part of a whole” (Webster’s Third New Int’l Dictionary at 1768), and neither claim 1 nor 12 Appeal 2017-000639 Application 13/682,406 claim 10 specifies structure for delineating one portion of an aperture from another (other than by their configuration to achieve a function), such that we are not apprised of error in the Examiner’s finding that the claimed second portion reads on only a portion of Rowland’s slit 24, and the claimed slit reads on another portion of Rowland’s slit 24. Accordingly, we sustain the Examiner’s rejection of claim 10 under 35 U.S.C. § 102(b) as anticipated by Rowland. Rejection II Claim 8, which depends from claim 7, further recites “wherein the neck portion comprises a tube coupled to the sheath, the tube defining an axial slit.” Appeal Br. 21 (Claims App’x). The Examiner relies on Viswanathan for teaching a tube (i.e., outer sheath 484) having an axial slit 480. Final Act. 4—5; see also Viswanathan 149 (“slit 480 preferably extends along a distal portion of the outer sheath 424, including some or all of the portion containing the lumen 430, providing access to the lumen from outside the outer sheath”). The Examiner reasons that it would have been obvious to modify Rowland by adding Viswanathan’s catheter tube (i.e., outer sheath 484) onto the end of the Rowland’s sheath (i.e., housing 14), “since Rowland calls for the addition of a tube onto the end of the catheter sleeve” and “to facilitate the positioning of the catheter tube.” Final Act. 5. Appellants argue that the Examiner admits that Rowland does not teach the limitation of claim 8, and submit that Viswanathan fails to teach the limitation as well. Appeal Br. 14. However, as discussed supra, the Examiner relies on Rowland for disclosing a sheath with a neck portion 13 Appeal 2017-000639 Application 13/682,406 (claim 7), as well as for suggesting an additional tubular member 36 for receiving a catheter (which still passes through a first aperture portion in certain embodiments), and on Viswanathan for teaching a tube (i.e., an outer sheath 424) with axial slit 480 (claim 8). See, e.g., Rowland 3:12—14 (“wall 32 is provided with a centrally disposed bore or aperture 34 having a tubular member 36 secured therein”), Fig. 3. The Examiner’s proposed modification is, therefore, to add Viswanathan’s outer sheath 424 with axial slit 480 to Rowland’s neck portion, as Rowland itself suggests adding an additional tube 36 at aperture 34. Thus, Appellants’ argument mischaracterizes the Examiner’s findings and does not address the rejection as articulated by the Examiner. Appellants also argue that “[tjhere is no reason to modify slit 24 of Rowland based on Viswanathan,” because “[s]lit 24 is only used in Rowland to allow the catheter to be moved into the opening 20.” Appeal Br. 14; see also Reply Br. 10 (arguing that the Examiner improperly relies on Rowland’s aperture 20 as the first and/or second portions of the aperture); see also id. (arguing that “[tjhere is simply no way the neck portion can be the curvature of the device and also be a tube coupled to the sheath”). However, Appellants’ arguments are not responsive to the rejection as articulated by the Examiner, as set forth supra. In other words, the Examiner is not proposing modifying, for example, Rowland’s slit 24; rather, the Examiner’s proposes adding Viswanathan’s outer sheath 484 with axial slit 480 to Rowland’s neck portion at aperture 20, similar to the 14 Appeal 2017-000639 Application 13/682,406 placement of Rowland’s additional tube 36. Ans. 10—11 (citing Viswanathan 149; Rowland, Fig. 3). Accordingly, we sustain the Examiner’s rejection of claim 8 under 35 U.S.C. § 103(a) as anticipated by Rowland and Viswanathan. Rejection III Claim 9, which depends from independent claim 1, further recites “wherein the catheter retainer comprises an integral8 conical portion of thick material that defines part or all of the second portion of the aperture, the thick material being thicker than material of the sheath. Appeal Br. 21 (Claims App’x). The Examiner relies on Nielsen for teaching a conical portion (i.e., “bottom end of 5”) that is integral to a sheath (i.e., envelope 4). Final Act. 5 (citing Nielsen, Fig. 1). The Examiner explains that “[t]he conical portion defines the bottom portion of the device which would have the aperture in Rowland,” and determines that “[t]he section has a thicker material” (i.e., cotton 8 and neck 5) “that makes the region thicker than the material of the sheath.” Id. The Examiner determines that, as modified, “[t]he cotton extends downward toward where the second aperture of Rowland would reside and can define part of the portion as required.” Ans. 11. The Examiner also explains that “Nielsen avoids the leakage of urine by using the cotton material,” and reasons that “[o]ne would be motivated to 8 There is no express definition for the claim term “integral” in the Specification. An ordinary meaning of “integral,” consistent with the Specification, is “of, or relating to, or serving to form a whole: essential for completeness: organically joined or linked.” Webster’s Third New Inf 1 Dictionary 1173 (1993). 15 Appeal 2017-000639 Application 13/682,406 modify Rowland by adding the cotton to the conical portion to prevent the leakage of urine.” Final Act. 5—6. Appellants argue that “[mjerely adding cotton inside the sheath of Rowland around the opening 20 . . . would not have any impact on the alleged second portion or slit 24.” Appeal Br. 16. Appellants also argue that “[njothing conical defines slit 24; merely adding a separate thicker material in the region of a linear slit does not make a conical portion that defines the slit.” Reply Br. 11. As set forth supra, the Examiner relies on Nielsen for disclosing an integral conical portion of thick material, a finding Appellants do not dispute. Therefore, Appellants’ argument that Rowland fails to define a conical section that defines part or all of Rowland’s slit 24 is not responsive to the rejection as articulated by the Examiner. Moreover, the Examiner proposes modifying Rowland’s cylindrical housing both at aperture 20 and extending downwardly to slit 24 to include a conical portion of thick material, as taught by Nielsen. Appellants’ arguments do not address the Examiner’s proposed modification or apprise us of error in the Examiner’s findings or reasoning. Accordingly, we sustain the Examiner’s rejection of claim 9 under 35 U.S.C. § 103(a) as anticipated by Rowland and Nielsen. Rejections IV and V Appellants chose not to present separate arguments for the patentability of claims 13—19, which depend from independent claim 1. 16 Appeal 2017-000639 Application 13/682,406 Appeal Br. 16. Therefore, for the reasons stated supra, we also sustain the Examiner’s rejection of such claims. Rejection VI Dependent claim 23 Claim 23, which depends from independent claim 1, further recites “wherein urine flow through the shaft of the urinary catheter is unobstructed when the shaft is retained in the second portion.” Appeal Br. 22 (Claims App’x) (emphasis added). The Examiner determines that although “Rowland does not say the catheter is completely obstructed when moved through the second aperture,” it would be obvious “to ensure the catheter is unobstructed when the shaft is retained to prevent turbulent flow through the catheter.” Final Act. 9. Appellants argue, inter alia, that, in Rowland, “the catheter is not retained in slit 24; rather, the catheter passes briefly through slit 24 on its way into opening 20.” Appeal Br. 18; see also Reply Br. 12. We are persuaded by Appellants’ argument. Although claim 1 merely requires the second portion of the aperture (i.e., Rowland’s slit 24) to be “configured to retain the shaft of the urinary catheter,” without specifying how such retention is achieved, claim 23, as set forth supra, requires the shaft to be retained in the second portion. A preponderance of evidence fails to support the Examiner’s finding that Rowland teaches that tube 12 is retained in slit 24; rather, as discussed supra, Rowland teaches that tube 12 is forced through slit 24. 17 Appeal 2017-000639 Application 13/682,406 Accordingly, we do not sustain the Examiner’s rejection of claim 23 under 35 U.S.C. § 103(a) as unpatentable over Rowland. Dependent claim 24 Claim 24, which depends from independent claim 1, further recites “wherein the second portion of the aperture forms a curved shape with a radius that is the same as or smaller than a radius of the shaft of the urinary catheter between a longitudinal axis of the shaft of the urinary catheter and an outer surface of the urinary catheter.” Appeal Br. 22 (Claims App’x). The Examiner finds that “Rowland teaches a curved shape aperture,” wherein “the aperture curves as the sheath bows out.” Final Act. 9 (citing Rowland, Fig. 1). The Examiner determines that “Rowland does not teach a radius but rather a slit that is smaller than the radius of the shaft.” Id. The Examiner reasons that it would have been obvious to modify Rowland’s attachment 10 “by replacing the slit with a circular opening to hold the catheter since the circular opening and the slit are functional equivalents.” Id. Appellants correctly argue that Rowland’s slit 24 “follows the radius of the cylindrical housing (14) which is substantially larger than the centrally disposed aperture (20),” which “‘is of a diametric size for snugly receiving the tube.’” Appeal Br. 18 (quoting Rowland 2:36—38). Thus, we agree with Appellants that although Rowland discloses a second portion (Rowland’s slit 24) that forms a curved shape, the radius is not the same as or smaller than a radius of the shaft of the urinary catheter, as claimed. Moreover, the Examiner does not provide factual support for determining 18 Appeal 2017-000639 Application 13/682,406 that a circular aperture is the functional equivalent for a slit used to place a housing over a tube in a transverse direction by forcing the tube through the slit. Accordingly, we do not sustain the Examiner’s rejection of claim 24 under 35 U.S.C. § 103(a) as unpatentable over Rowland. DECISION The Examiner’s rejection of claims 1—3, 5—7, 10, 12, and 20 under 35 U.S.C. § 102(b) as anticipated by Rowland is AFFIRMED. The Examiner’s rejection of claim 4 under 35 U.S.C. § 102(b) as anticipated by Rowland is REVERSED. The Examiner’s rejection of claim 8 under 35 U.S.C. § 103(a) as unpatentable over Rowland and Viswanathan is AFFIRMED. The Examiner’s rejection of claim 9 under 35 U.S.C. § 103(a) as unpatentable over Rowland and Nielsen is AFFIRMED. The Examiner’s rejection of claims 13—17 and 19 under 35 U.S.C. § 103(a) as unpatentable over Rowland and Cisko is AFFIRMED. The Examiner’s rejection of claim 18 under 35 U.S.C. § 103(a) as unpatentable over Rowland, Cisko, and Highgate is AFFIRMED. The Examiner’s rejection of claims 23 and 24 under 35 U.S.C. § 103(a) as unpatentable over Rowland is REVERSED. 19 Appeal 2017-000639 Application 13/682,406 No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). See 37 C.F.R. § 1.136(a)(l)(iv). AFFIRMED-IN—PART 20 Copy with citationCopy as parenthetical citation